ACEA Pharma Acquired by Phoenix Asia Holdings | Healthcare M&A Deal

Phoenix Asia Holdings has completed the acquisition of ACEA Pharma, a pharmacy business in Cayman Islands, for $1,000,000,000. ACEA Pharma operates in healthcare pharmacy, and the buyer is pursuing a strategic acquisition to expand its pharmaceutical footprint through a merger acquisition structure. The go-forward company is expected to be renamed ACEA Pharma, Inc., with common stock anticipated to list on Nasdaq after closing in the second quarter of 2026, subject to regulatory and stock exchange approvals. Phoenix Asia Holdings acquisitions represent a strategic acquisition by a strategic buyer, with ACEA Therapeutics and ACEA Pharma subsidiaries transferring 100% of ACEA Pharma equity for newly issued Phoenix shares at $10.00 per share.